Clinical trial

Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics

NCT00668395

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-05-01

PhaseNA

Study timeline

Study start (unknown)2007-05-01Date precision: month

Registry last updated2014-09-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

EfavirenzDRUG · verified · RxNorm: efavirenz

Sponsors & collaborators

Indiana Universitylead sponsor

Mapped research locations

IndianapolisIndiana, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00668395 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.